39 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
the participant’s death, (ii) transfer an award to a former spouse as required by a domestic relations order incident to a divorce, or (iii) otherwise transfer
8-K
EX-3.1
8ytiqp6
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
PRE 14A
mcx8k37
1 Sep 21
Preliminary proxy
4:46pm
8-K
EX-1.1
unqkno 3i0yev
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
424B3
je2p21hsa gvazuuz634
12 Apr 21
Prospectus supplement
1:44pm
S-3
kq4c3 btzkt4wano
2 Apr 21
Shelf registration
12:00am